Eye Tumor Research Foundation Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 75,060 | 88,190 | −13,130 | 30.0 | — |
| 2012 | 75,982 | 77,361 | −1,379 | 34.5 | — |
| 2013 | 78,788 | 58,948 | 19,840 | 51.2 | — |
| 2014 | 226,756 | 51,715 | 175,041 | 100.4 | 19% |
| 2015 | 124,494 | 53,476 | 71,018 | 109.2 | 38% |
| 2016 | 271,805 | 82,764 | 189,041 | 100.5 | 49% |
| 2017 | 174,196 | 85,208 | 88,988 | 108.2 | 37% |
| 2018 | 137,438 | 98,713 | 38,725 | 95.7 | 16% |
| 2019 | 146,745 | 108,110 | 38,635 | 93.5 | 8% |
| 2020 | 171,343 | 117,194 | 54,149 | 92.0 | 36% |
| 2021 | 203,641 | 127,119 | 76,522 | 92.7 | 25% |
| 2022 | 112,489 | 165,556 | −53,067 | 62.5 | 25% |
| 2023 | 152,665 | 208,376 | −55,711 | 50.3 | 24% |
In its most recent public year (2023), this organization spent $55,711 more than it brought in. Its reserves stood at about 50.3 months of spending, up from 30 in 2011. Staff pay was 24% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works